| 000 | 01024 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514200345.0 | ||
| 264 | 0 | _c20040924 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0004-3591 | ||
| 024 | 7 |
_a10.1002/art.20387 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJean, R | |
| 245 | 0 | 0 |
_aIntravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cAug 2004 |
||
| 300 |
_a2711; author reply 2711-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntiphospholipid Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 | _aSafety |
| 700 | 1 | _aBastard, E | |
| 700 | 1 | _aCretel, E | |
| 700 | 1 | _aLefèvre, P | |
| 700 | 1 | _aDurand, J M | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 50 _gno. 8 _gp. 2711; author reply 2711-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.20387 _zAvailable from publisher's website |
| 999 |
_c15031915 _d15031915 |
||